20-YEAR STEADY INCREASE IN POST-ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OUTCOMES FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A REPORT FROM THE EBMT ACUTE LEUKEMIA WORKING PARTY

被引：0

作者：

Bazarbachi, Ali ^{[1
]}

Labopin, Myriam ^{[2
]}

Moukalled, Nour ^{[1
]}

Kroeger, Nicolaus ^{[3
]}

Rautenberg, Christina ^{[4
]}

Schetelig, Johannes ^{[5
]}

Finke, Jurgen ^{[6
]}

Blau, Igor Wolfgang ^{[7
]}

Blaise, Didier ^{[8
]}

Stelljes, Matthias ^{[9
]}

Eder, Matthias ^{[10
]}

Platzbecker, Uwe ^{[11
]}

Dreger, Peter ^{[12
]}

Bethge, Wolfgang ^{[13
]}

Tischer, Johanna ^{[14
]}

Burns, David ^{[15
]}

Sengeloev, Henrik ^{[16
]}

Brissot, Eolia ^{[17
]}

Giebel, Sebastian ^{[18
]}

Nagler, Arnon ^{[19
]}

Ciceri, Fabio ^{[20
]}

Mohty, Mohamad ^{[21
]}

机构：

[1] Amer Univ Beirut, Med Ctr, Beirut, Lebanon

[2] Sorbonne Univ, St Antoine Hosp, EBMT Stat Unit, Paris, France

[3] Univ Med Ctr, Hamburg, Germany

[4] Univ Hosp Essen, Essen, Germany

[5] Univ Klinikum Dresden, Dresden, Germany

[6] Univ Freiburg, Fribourg, Switzerland

[7] Med Klin MS Hamatol Onkol & Tumorimmunol, Berlin, Germany

[8] Aix Marseille Univ, Inst Paoli Calmettes, MSC Lab, Marseille, France

[9] Univ Hosp Muenster, Munster, Germany

[10] Hannover Med Sch, Hannover, Germany

[11] Med Clin & Policin 1, Leipzig, Germany

[12] Heidelberg Univ, Heidelberg, Germany

[13] Univ Hosp Tuebingen, Tubingen, Germany

[14] LMU Univ Hosp, Munich, Germany

[15] Univ Hosp Birmingham NHSTrust, Birmingham, W Midlands, England

[16] Rigshosp, Herlev, Denmark

[17] Sorbonne Univ, Paris, France

[18] Maria Sklodowska Curie Natl Res Inst Oncol, Gliwice, Poland

[19] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel

[20] IRCCS Osped San Raffaele, Milan, Italy

[21] Sorbonne Univ, St Antoine Hosp, Paris, France

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O017

引用

页码：26 / 27

页数：2

共 50 条

[21] Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT
Christopeit, Maximilian
Labopin, Myriam
Gorin, Norbert-Claude
Saraceni, Francesco
Passweg, Jakob
Forcade, Edouard
Maertens, Johan
Van Lint, Maria Teresa
Bosi, Alberto
Niederwieser, Dietger
Ehninger, Gerhard
Polge, Emmanuelle
Mohty, Mohamad
Nagler, Arnon
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1532 - 1542
[22] Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia
Appelbaum, Frederick R.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (04)
[23] Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia
Levin-Epstein, Rebecca
Oliai, Caspian
Schiller, Gary
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (12)
[24] Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia
Rebecca Levin-Epstein
Caspian Oliai
Gary Schiller
Current Treatment Options in Oncology, 2018, 19
[25] OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ACUTE LEUKEMIA ABOVE 70 YEARS OF AGE: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT
Ringden, O.
Boumendil, A.
Labopin, M.
Sadeghi, B.
Savani, B.
Mohty, M.
Nagler, A.
HAEMATOLOGICA, 2017, 102 : 130 - 130
[26] Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT
Munker, Reinhold
Labopin, Myriam
Esteve, Jordi
Schmid, Christoph
Mohty, Mohamad
Nagler, Arnon
HAEMATOLOGICA, 2017, 102 (12) : 2134 - 2140
[27] ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS OLDER THAN 60 YEARS: A SURVEY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT
Guepin, G. Roth
Labopin, M.
Ruggeri, A.
Polge, E.
Finke, J.
Cornelissen, J.
Fegueux, N.
Stuhler, G.
Rovira, M.
Potter, M.
Ganser, A.
Veelken, H.
Cahn, J. Y.
Collin, M.
Beguin, Y.
Giebel, S.
Nagler, A.
Mohty, M.
HAEMATOLOGICA, 2015, 100 : 14 - 14
[28] The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)
Poiani, Monica
Labopin, Myriam
Battipaglia, Giorgia
Beelen, Dietrich W.
Tischer, Johanna
Finke, Juergen
Brecht, Arne
Forcade, Edouard
Ganser, Arnold
Passweg, Jakob R.
Labussiere-Wallet, Helene
Yakoub-Agha, Ibrahim
Schaefer-Eckart, Kerstin
Kroeger, Nicolaus
Guffroy, Blandine
Ruggeri, Annalisa
Esteve, Jordi
Nagler, Arnon
Mohty, Mohamad
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : 40 - 50
[29] Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia
Yalniz, Fevzi F.
Saliba, Rima M.
Greenbaum, Uri
Ramdial, Jeremy
Popat, Uday
Oran, Betul
Alousi, Amin
Olson, Amanda
Alatrash, Gheath
Marin, David
Rezvani, Katayoun
Hosing, Chitra
Im, Jin
Mehta, Rohtesh
Qazilbash, Muzaffar
Joseph, Jacinth Joy
Rondon, Gabriela
Kanagal-Shamanna, Rashmi
Shpall, Elizabeth
Champlin, Richard
Kebriaei, Partow
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (08): : 689 - 695
[30] Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Myeloid Leukemia
Yalniz, Fevzi
Saliba, Rima
Greenbaum, Uri
Ramdial, Jeremy
Alousi, Amin
Joseph, Jacinth
Olson, Amanda
Alatrash, Gheath
Marin, David
Rezvani, Katayoun
Hosing, Chitra
Im, Jin
Shpall, Elizabeth
Mehta, Rohtesh
Qazilbash, Muzaffar
Popat, Uday
Oran, Betul
Champlin, Richard
Kebriaei, Partow
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S202 - S202

← 1 2 3 4 5 →